Literature DB >> 16877648

Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study.

Benjamin Vicente1, Robert Kohn, Pedro Rioseco, Sandra Saldivia, Itzhak Levav, Silverio Torres.   

Abstract

OBJECTIVE: Although several epidemiological studies of the prevalence of psychiatric disorders have been conducted in Latin America, few of them were national studies that could be used to develop region-wide estimates. Data are presented on the prevalence of DSM-III-R disorders, demographic correlates, comorbidity, and service utilization in a nationally representative adult sample from Chile.
METHOD: The Composite International Diagnostic Interview was administered to a stratified random sample of 2,978 individuals from four provinces representative of the country's population age 15 and older. Lifetime and 12-month prevalence rates were estimated.
RESULTS: Approximately one-third (31.5%) of the population had a lifetime psychiatric disorder, and 22.2% had a disorder in the past 12 months. The most common lifetime psychiatric disorders were agoraphobia (11.1%), social phobia (10.2%), simple phobia (9.8%), major depressive disorder (9.2%), and alcohol dependence (6.4%). Of those with a 12-month prevalence diagnosis, 30.1% had a comorbid psychiatric disorder. The majority of those with comorbidity had sought out mental health services, in contrast to one-quarter of those with a single disorder.
CONCLUSIONS: The prevalence rates in Chile are similar to those obtained in other studies conducted in Latin America and Spanish-speaking North American groups. Comorbidity and alcohol use disorders, however, were not as prevalent as in North America.

Entities:  

Mesh:

Year:  2006        PMID: 16877648     DOI: 10.1176/ajp.2006.163.8.1362

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

Review 1.  Cultural aspects in social anxiety and social anxiety disorder.

Authors:  Stefan G Hofmann; M A Anu Asnaani; Devon E Hinton
Journal:  Depress Anxiety       Date:  2010-12       Impact factor: 6.505

2.  Comparison of the consumption of antidepressants in the immigrant and native populations in a Spanish health region: an observational study.

Authors:  Inés Cruz; Catalina Serna; Jordi Real; Montse Rué; Jorge Soler; Leonardo Galván
Journal:  BMC Public Health       Date:  2010-05-17       Impact factor: 3.295

3.  Prevalence, trends, correlates and treatment of depression in Chile in 2003 to 2010.

Authors:  Niina Markkula; Pedro Zitko; Sebastián Peña; Paula Margozzini; Pedro Retamal C
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-02-14       Impact factor: 4.328

Review 4.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

5.  Prevalence of mental disorders at admission to the penal justice system in emerging countries: a study from Chile.

Authors:  A P Mundt; S Kastner; S Larraín; R Fritsch; S Priebe
Journal:  Epidemiol Psychiatr Sci       Date:  2015-06-19       Impact factor: 6.892

6.  Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.

Authors:  Rachel H Salk; Janet S Hyde; Lyn Y Abramson
Journal:  Psychol Bull       Date:  2017-04-27       Impact factor: 17.737

Review 7.  Specific phobias.

Authors:  William W Eaton; O Joseph Bienvenu; Beyon Miloyan
Journal:  Lancet Psychiatry       Date:  2018-08       Impact factor: 27.083

8.  Correlates of lifetime alcohol misuse among older community residents in Brazil.

Authors:  Sergio Luís Blay; Gerda G Fillenbaum; Sergio Baxter Andreoli; Fábio Leite Gastal
Journal:  Int Psychogeriatr       Date:  2009-01-13       Impact factor: 3.878

9.  Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis.

Authors:  Dan Chisholm; Oye Gureje; Sandra Saldivia; Marcelo Villalón Calderón; Rajitha Wickremasinghe; Nalaka Mendis; Jose-Luis Ayuso-Mateos; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 10.  Vagus nerve stimulation for epilepsy and depression.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.